Analyst Research: Allergan Inc (AGN)

AGN on New York Consolidated

162.11USD
28 Aug 2014
Price Change (% chg)

$-0.65 (-0.40%)
Prev Close
$162.76
Open
$161.47
Day's High
$163.98
Day's Low
$161.27
Volume
1,545,740
Avg. Vol
2,494,991
52-wk High
$174.49
52-wk Low
$86.95

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - ALLERGAN, INC. (AGN-N) 5:41am EDT Thomson Reuters Stock Report 12 25.00
Trading Report for (AGN). A detailed report, including free correlated market analysis, and updates. 27 Aug 2014 Stock Traders Daily 10 20.00
Wright Investors Service Comprehensive Report for Allergan, Inc. 25 Aug 2014 Wright Reports 56 75.00
ValuEngine Rating and Forecast Report for AGN 24 Aug 2014 ValuEngine, Inc. 11 25.00
Allergan, Inc 23 Aug 2014 S&P Capital IQ – STARS Reports 11 127.00
ALLERGAN INC (AGN) 12-months forecast 22 Aug 2014 Pechala's Reports 1 15.00
ALLERGAN INC (AGN) - REPORT FOR ACTIVE TRADERS 22 Aug 2014 Pechala's Reports 1 25.00
Allergan Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 22 Aug 2014 Reuters Investment Profile 12 20.00
Value Graph: ALLERGAN -- AGN 21 Aug 2014 Ford Investor Services, Inc. 1 12.00
TheStreet.com Ratings Stock Report For: ALLERGAN INC (AGN) 16 Aug 2014 TheStreet.com Ratings 5 10.00
 
Name Age Since Current Position

David Pyott

60 2013 Chairman of the Board, Chief Executive Officer, Principal Executive Officer

Douglas Ingram

51 2013 President

James Hindman

54 2014 Chief Financial Officer, Executive Vice President - Finance and Business Development

Scott Whitcup

54 2009 Executive Vice President - Research & Development, Chief Scientific Officer

Arnold Pinkston

55 2011 Executive Vice President, General Counsel, Assistant Secretary
Search Stocks